During the past decade, CHU Saint-Etienne Pneumologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU Saint-Etienne Pneumologie" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Ligue contre le cancer, France" with 1 trials as a collaborator and "Pierre Fabre Laboratories" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "CHU Saint-Etienne Pneumologie" are "Concomitant Radiochemotherapy" (1 trials), "Lung Adenocarcinoma With Bronchiolo-alveolar Feature" (1 trials), "Metastatic NSCLC" (1 trials), "NSCLC Stage IIIB" (1 trials) and "Non-squamous Non-small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "CHU Saint-Etienne Pneumologie" in a lesser frequency.

Most popular intervention types in "CHU Saint-Etienne Pneumologie" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "Chemotherapy" (1 trials), "Docetaxel" (1 trials), "Gefitinib" (1 trials) and "Paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHU Saint-Etienne Pneumologie" are 4 trials for "All" genders.

Currently, there are NaN active trials in "CHU Saint-Etienne Pneumologie". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in CHU Saint-Etienne Pneumologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CHU Saint-Etienne Pneumologie, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".